-transparent.png){kind=logo}
Aspirin and indomethacin decreased the hydrolysis of microsomal phospholipids by exogenous soluble phospholipase A2 and increased lipid peroxidation in rat liver microsomes. Copper chelates of the non-steroidal anti-inflammatory drugs tested more strongly decreased the activity of soluble phospholipase A2 as compared to the ligands. In contrast to the stimulant effects of aspirin and indomethacin these chelates exerted dose-dependent inhibitory effects on enzymatic and non-enzymatic lipid peroxidation. The effects of CuSO4 were similar to those of Cu(II)-aspirin and Cu(II)-indomethacin. Bathocuproine sulfonate, a specific chelator for Cu+, completely prevented the inhibitory effects of copper complexes and of CuSO4 both on lipid peroxidation and on microsomal NADPH-oxidation. Therefore, cupric ions, free or chelated, as well as their reduction to Cu+ by microsomes did not affect the activity of NADPH-dependent cytochrome P-450 reductase. These data are explained by drug-induced changes in the membrane structure as well as by the redox cycling of cupric ions in the copper complexes of aspirin and indomethacin and the subsequent and/or simultaneous interaction of Cu2+/Cu+ with some component(s) of the reaction medium.
E M Russanov, and
D E Dimitrova, and
E A Ivancheva, and
M D Kirkova
October 1978,
Lipids,
E M Russanov, and
D E Dimitrova, and
E A Ivancheva, and
M D Kirkova
February 1980,
FEBS letters,
E M Russanov, and
D E Dimitrova, and
E A Ivancheva, and
M D Kirkova
January 1986,
Free radical research communications,
E M Russanov, and
D E Dimitrova, and
E A Ivancheva, and
M D Kirkova
December 1980,
Biochimica et biophysica acta,
E M Russanov, and
D E Dimitrova, and
E A Ivancheva, and
M D Kirkova
January 1980,
Journal of nutritional science and vitaminology,
E M Russanov, and
D E Dimitrova, and
E A Ivancheva, and
M D Kirkova
July 1974,
Biochemical pharmacology,
E M Russanov, and
D E Dimitrova, and
E A Ivancheva, and
M D Kirkova
March 1980,
Chemical & pharmaceutical bulletin,
E M Russanov, and
D E Dimitrova, and
E A Ivancheva, and
M D Kirkova
June 1977,
Japanese journal of pharmacology,
E M Russanov, and
D E Dimitrova, and
E A Ivancheva, and
M D Kirkova
February 1985,
Chemical & pharmaceutical bulletin,
E M Russanov, and
D E Dimitrova, and
E A Ivancheva, and
M D Kirkova
January 1989,
Chemico-biological interactions,
